Can perioperative chemotherapy for advanced gastric cancer be recommended on the basis of current research? A critical analysis

Journal of Gastric Cancer

Volumn 14, Issue 1, 2014, Pages 39-46

  Bauer, Katrin ^a   Porzsolt, Franz ^b   Henne Bruns, Doris ^b  

^a Kempten Hospital   (Germany)

^b UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Cancer of the esophagogastric junction; Lower esophageal cancer; Perioperative chemotherapy; Stomach neoplasms

Indexed keywords

CISPLATIN; FLUOROURACIL; FOLIC ACID;

ABDOMINAL RADIOGRAPHY; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL RESEARCH; COMPUTER ASSISTED TOMOGRAPHY; ENDOSCOPY; HUMAN; LOWER ESOPHAGUS SPHINCTER; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; OVERALL SURVIVAL; PRACTICE GUIDELINE; QUESTIONNAIRE; STOMACH CANCER; WORLD HEALTH ORGANIZATION;

EID: 84897940415     PISSN: 2093582X     EISSN: 20935641     Source Type: Journal    
DOI: 10.5230/jgc.2014.14.1.39     Document Type: Article

References (22)

1. World Cancer Research Fund International. Cancer frequency by country, Source: GLOBOCAN 2008 database (version 1.2) [Internet]. London: World Cancer Research Fund International; 2008 [updated 2014 Feb 14]. Available from: www.wcrf.org.
2. Robert-Koch-Institut. Cancer in Germany, friquencies and trends.222.rki/krebs.de [Internet]. Berlin: Robert-Koch-Institut; 2010 [updated 2013 Dec 13]. Available from: http://www.krebsdaten.de/Krebs/DE/Content/Krebsarten/Magenkrebs/magenkrebs_node.html.
3. Verdecchia A, Francisci S, Brenner H, Gatta G, Micheli A, Mangone L, et al. Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol 2007;8:784-796.
4. GASTRIC (Global Advanced/Adjuvant Stomach Tumor Research International Collaboration) Group, Paoletti X, Oba K, Burzykowski T, Michiels S, Ohashi Y, et al. Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis. JAMA 2010;303:1729-1737.
5. Janunger KG, Hafström L, Glimelius B. Chemotherapy in gastric cancer: a review and updated meta-analysis. Eur J Surg 2002;168:597-608.
6. Moehler M, Al-Batran SE, Andus T, Anthuber M, Arends J, Arnold D, et al. German S3-guideline Diagnosis and treatment of esophagogastric cancer. Z Gastroenterol 2011;49:461-531.
7. Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006;355:11-20.
8. Schuhmacher C, Gretschel S, Lordick F, Reichardt P, Hohenberger W, Eisenberger CF, et al. Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954. J Clin Oncol 2010;28:5210-5218.
9. Ychou M, Boige V, Pignon JP, Conroy T, Bouché O, Lebreton G, et al. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J Clin Oncol 2011;29:1715-1721.
10. Porzsolt F, Braubach P, Flurschütz PI, Göller A, Sailer MB, Weiss M, et al. Medical students can help avoid the expert bias in medicine. Creat Educ 2012;3:1115-1121.
11. Bauer K, Porzsolt F, Henne-Bruns D. Validity of the MAGIC study: sufficient for recommendations? Hepatogastroenterology 2013;60:1822-1824.
12. Taves DR. Minimization: a new method of assigning patients to treatment and control groups. Clin Pharmacol Ther 1974;15:443-453.
13. Pocock SJ, Simon R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 1975;31:103-115.
14. Scott NW, McPherson GC, Ramsay CR, Campbell MK. The method of minimization for allocation to clinical trials. a review. Control Clin Trials 2002;23:662-674.
15. Hartgrink HH, van de Velde CJ, Putter H, Songun I, Tesselaar ME, Kranenbarg EK, et al. Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial. Eur J Surg Oncol 2004;30:643-649.
16. Wittekind C, Bertolini J. TNM-system 2010. Onkol 2010;16: 175-180.
17. Rice TW, Rusch VW, Ishwaran H, Blackstone EH; Worldwide Esophageal Cancer Collaboration. Cancer of the esophagus and esophagogastric junction: data-driven staging for the seventh edition of the American Joint Committee on Cancer/ International Union Against Cancer Cancer Staging Manuals. Cancer 2010;116:3763-3773.
18. Power DG, Schattner MA, Gerdes H, Brenner B, Markowitz AJ, Capanu M, et al. Endoscopic ultrasound can improve the selection for laparoscopy in patients with localized gastric cancer. J Am Coll Surg 2009;208:173-178.
19. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. an attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965;64:31-49.
20. Songun I, Putter H, Kranenbarg EM, Sasako M, van de Velde CJ. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol 2010;11:439-449.
21. Lachin JM. Statistical considerations in the intent-to-treat principle. Control Clin Trial 2000;21:167-189.
22. Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 1985;312:1604-1608.